Cargando…

Increased HBV Coinfection and Decreased IFN-γ-Producing HBV-Specific CD8+ T Cell Numbers During HIV Disease Progression

OBJECTIVE: To investigate the characteristics and mechanism of the dynamics of HBV infection with the progression of HIV disease and to explore the different responses of T lymphocytes to HBV in HIV patients in different stages of disease. METHODS: We compared the rates and characteristics of HBV co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Zhiqiang, Qin, Yuanyuan, Liang, Qi, Xia, Wei, Zhang, Tong, Wang, Wen, Zhang, Mengmeng, Jiang, Taiyi, Wu, Hao, Tian, Ye
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005981/ https://www.ncbi.nlm.nih.gov/pubmed/35432386 http://dx.doi.org/10.3389/fimmu.2022.861804

Ejemplares similares

Incidence and predictors of HBV functional cure in patients with HIV/HBV coinfection: A retrospective cohort study
por: Zhang, Qingrong, et al.
Publicado: (2023)

HBV-Specific CD8+ T-Cell Tolerance in the Liver
por: Baudi, Ian, et al.
Publicado: (2021)

Functional Exhaustion of HBV-Specific CD8 T Cells Impedes PD-L1 Blockade Efficacy in Chronic HBV Infection
por: Ferrando-Martinez, Sara, et al.
Publicado: (2021)

Immunological Efficacy of Tenofovir Disproxil Fumarate-Containing Regimens in Patients With HIV-HBV Coinfection: A Systematic Review and Meta-Analysis
por: Jiang, Taiyi, et al.
Publicado: (2019)

Heterogeneity of HBV-Specific CD8(+) T-Cell Failure: Implications for Immunotherapy
por: Heim, Kathrin, et al.
Publicado: (2019)

IFNα subtype-specific susceptibility of HBV in the course of chronic infection
por: Xie, Xiaohong, et al.
Publicado: (2022)

Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV
por: Tseng, Chih-Wei, et al.
Publicado: (2022)

HBV genotypes and response to tenofovir disoproxil fumarate in HIV/HBV-coinfected persons
por: Bihl, Florian, et al.
Publicado: (2015)

Decreased granzyme-B expression in CD11c(+)CD8(+) T cells associated with disease progression in patients with HBV-related hepatocellular carcinoma
por: Gao, Lin, et al.
Publicado: (2023)

IFN-γ: A Crucial Player in the Fight Against HBV Infection?
por: Hillaire, Marine Laure Bettina, et al.
Publicado: (2023)

Chances for cure in chronic HBV/HDV coinfection
por: Iliescu, Gabriela, et al.
Publicado: (2014)

Suppression of HBV by Tenofovir in HBV/HIV Coinfected Patients: A Systematic Review and Meta-Analysis
por: Price, Huw, et al.
Publicado: (2013)

Treatment advantage in HBV/HIV coinfection compared to HBV monoinfection in a South African cohort
por: Maponga, Tongai G., et al.
Publicado: (2020)

Risk of HBV Reactivation in Patients With Resolved HBV Infection Receiving Anti-CD19 Chimeric Antigen Receptor T Cell Therapy Without Antiviral Prophylaxis
por: Li, Ping, et al.
Publicado: (2021)

Assessment of HBV flare in a randomized clinical trial in HIV/HBV coinfected subjects initiating HBV-active antiretroviral therapy in Thailand
por: Avihingsanon, Anchalee, et al.
Publicado: (2012)

Host immunity and HBV S gene mutation in HBsAg-negative HBV-infected patients
por: Liu, Xin, et al.
Publicado: (2023)

Association of IFN-γ gene polymorphism and levels in HBV related disease chronicity in India
por: Saxena, Roli, et al.
Publicado: (2012)

HBV influence on Response to Antiretroviral Therapy in Horizontally HIV-HBV Coinfected Patient during Early Childhood
por: Niculescu, Irina, et al.
Publicado: (2013)

NKG2C(+) natural killer cell function improves the control of HBV replication in individuals with acute HIV infection coinfected with HBV
por: Song, Ting, et al.
Publicado: (2020)

HIV-HBV Coinfection—Current Challenges for Virologic Monitoring
por: Ruta, Simona, et al.
Publicado: (2023)

PD-L1 upregulation by IFN-α/γ-mediated Stat1 suppresses anti-HBV T cell response
por: Liu, LanLan, et al.
Publicado: (2020)

Inhibition of HBV Expression in HBV Transgenic Mice Using AAV-Delivered CRISPR-SaCas9
por: Li, Hao, et al.
Publicado: (2018)

Emergence of Lamivudine-Resistant HBV during Antiretroviral Therapy Including Lamivudine for Patients Coinfected with HIV and HBV in China
por: Gu, Lijun, et al.
Publicado: (2015)

1248. Relationship Between ALT and New HBV Biomarkers in HBV/HIV Coinfected Persons Started on Antiviral Therapy
por: Rouster, Susan D, et al.
Publicado: (2022)

Establishment of Humanized Mice for the Study of HBV
por: Lai, Fritz, et al.
Publicado: (2021)

HBV-HCV Coinfection: Viral Interactions, Management, and Viral Reactivation
por: Mavilia, Marianna G., et al.
Publicado: (2018)

Prevalence of HCV and/or HBV coinfection in Iranian HIV-infected patients
por: Dehghani-Dehej, Farzaneh, et al.
Publicado: (2020)

Patients with COVID-19 and HBV Coinfection are at Risk of Poor Prognosis
por: Yang, Shanshan, et al.
Publicado: (2022)

Prevalence and characteristics of HIV/HBV and HIV/HCV coinfections in Tuscany
por: Puglia, Monia, et al.
Publicado: (2015)

Analysis of HBV and COVID-19 Coinfection Model with Intervention Strategies
por: Teklu, Shewafera Wondimagegnhu
Publicado: (2023)

Role of STAT1 in the resistance of HBV to IFN-α
por: Xu, Bingfa, et al.
Publicado: (2021)

Decreased Siglec-9 Expression on Natural Killer Cell Subset Associated With Persistent HBV Replication
por: Zhao, Di, et al.
Publicado: (2018)

CD45RA, CD8β, and IFNγ Are Potential Immune Biomarkers of Human Cognitive Function
por: Esgalhado, André J., et al.
Publicado: (2020)

Study on pathological and clinical characteristics of chronic HBV infected patients with HBsAg positive, HBV DNA negative, HBeAg negative
por: Zeng, Zhan, et al.
Publicado: (2023)

Editorial: Recent Advances in HBV and HCV Immunology
por: Dustin, Lynn B., et al.
Publicado: (2015)

HBV-Induced Immune Imbalance in the Development of HCC
por: Chen, Yongyan, et al.
Publicado: (2019)

Interferon and interferon-stimulated genes in HBV treatment
por: Li, Qirong, et al.
Publicado: (2022)

Type-I-IFN-Stimulated Gene TRIM5γ Inhibits HBV Replication by Promoting HBx Degradation
por: Tan, Guangyun, et al.
Publicado: (2019)

The Predictive Role of Hepatitis B Biomarkers on HBV Reactivation following Direct-Acting Antiviral Therapy in HBV/HCV Coinfected Patients
por: Tseng, Chih-Wei, et al.
Publicado: (2022)

High rates of hepatitis B virus (HBV) functional cure among HIV/HBV coinfected Chinese adults on antiretroviral therapy
por: Xia, Huan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jqnqqqf76g1ho005iupr551lge